首页> 外文OA文献 >Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents

【2h】

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents

机译：维达列汀，沙格列汀或西他列汀作为中国传统的口服降糖药双重控制不足的2型糖尿病患者的附加治疗的有效性和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Chun-Jun Li; Xiao-Juan Liu; Lian Bai; Qian Yu; Qiu-Mei Zhang; Pei Yu; De-Min Yu;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents [J] . Chun-Jun Li, Xiao-Juan Liu, Lian Bai, Diabetology and Metabolic Syndrome . 2014,第1期

机译：维达列汀，沙格列汀或西他列汀作为中国传统口服降糖药双重控制不足的2型糖尿病患者的附加治疗的有效性和安全性
2. Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes. [J] . C-J Li, Q Yu, P Yu, Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association . 2014,第8期

机译：利拉鲁肽，沙格列汀和维达列汀联合目前的常规口服降糖药治疗在控制不佳的中国2型糖尿病中的疗效和安全性比较。
3. Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes. [J] . C-J Li, Q Yu, P Yu, Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association . 2014,第8期

机译：荔枝蛋白酶，Saxagliptin和Vilyagliptin附加治疗的疗效和安全比较，均结合目前常规口腔降糖药物治疗患者患者急性患者2型糖尿病。
4. Nonadherence to Oral Antihyperglycemic Agents: Subsequent Hospitalization and Mortality among Patients with Type 2 Diabetes in Clinical Practice [C] . Vivienne J. Zhu, Wanzhu Tu, Marc B. Rosenman, MEDINFO . 2015

机译：口服抗血糖剂：临床实践中2型糖尿病患者的随后住院和死亡率
5. The relationship between the emotional burden of Type 2 Diabetes and glycemic control and differences in emotional burden and glycemic control among individuals treated with oral antidiabetic agents, combination therapy, incretin mimetic, and insulin [D] . Douaihy, Katharine 2008

机译：2型糖尿病患者的情绪负担与血糖控制之间的关系以及口服抗糖尿病药，联合疗法，降钙素模拟物和胰岛素治疗的个体之间情绪负担和血糖控制的差异
6. Efficacy and safety of vildagliptin Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents [O] . Chun-Jun Li, Xiao-Juan Liu, Lian Bai, 2014

机译：维达列汀沙格列汀或西他列汀作为中国传统的口服降糖药双重控制不足的2型糖尿病患者的附加治疗的有效性和安全性
7. Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent [O] . 2015

机译：维格列汀，西他列汀和利拉列汀作为补充治疗在胰岛素和传统口服降糖药双重控制不足的中国T2DM患者中的疗效和安全性

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents

著录项

相似文献

相关主题

期刊订阅